ArticleThe Lancet regional health. Southeast Asia2026
Mortality and cost of therapy of carbapenem susceptible vs resistant Gram-negative infections among hospitalised patients in India: a multicentric surveillance (2022-2025).
Nitin Bansal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.